Ascelia Pharma AB's total assets for Q4 2025 were kr111.94M, a decrease of -17.94% from the previous quarter. SE:ACE total liabilities were kr12.47M for the fiscal quarter, a -43.36% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.